Efficacy and Safety of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia
Clinical trial NCT00639483 · COMPLETED
Trial details
- NCT number
- NCT00639483
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.